306 related articles for article (PubMed ID: 30103303)
1. Taurine, glutamic acid and ethylmalonic acid as important metabolites for detecting human breast cancer based on the targeted metabolomics.
Wang X; Zhao X; Chou J; Yu J; Yang T; Liu L; Zhang F
Cancer Biomark; 2018; 23(2):255-268. PubMed ID: 30103303
[TBL] [Abstract][Full Text] [Related]
2. Human plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer.
Fan Y; Zhou X; Xia TS; Chen Z; Li J; Liu Q; Alolga RN; Chen Y; Lai MD; Li P; Zhu W; Qi LW
Oncotarget; 2016 Mar; 7(9):9925-38. PubMed ID: 26848530
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer detection using targeted plasma metabolomics.
Jasbi P; Wang D; Cheng SL; Fei Q; Cui JY; Liu L; Wei Y; Raftery D; Gu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():26-37. PubMed ID: 30562627
[TBL] [Abstract][Full Text] [Related]
4. Exploring pathogenesis in subjects with subjective Tinnitus having kidney deficiency pattern in terms of Traditional Chinese Medicine based on serum metabolic profiles.
Tan Y; Lu C; Jiang M; Zhao N; Li L; Shen S; Guan F; He B; Xiao C; L A; Cheng S; Zu X; Zhang W; Liu X
J Tradit Chin Med; 2018 Oct; 38(5):773-780. PubMed ID: 32185996
[TBL] [Abstract][Full Text] [Related]
5. Saturated fatty acids as possible important metabolites for epithelial ovarian cancer based on the free and esterified fatty acid profiles determined by GC-MS analysis.
Yin R; Yang T; Su H; Ying L; Liu L; Sun C
Cancer Biomark; 2016 Sep; 17(3):259-269. PubMed ID: 27802202
[TBL] [Abstract][Full Text] [Related]
6. Plasma metabolomic profiling of central serous chorioretinopathy.
Xu H; Huang L; Jin E; Liang Z; Zhao M
Exp Eye Res; 2021 Feb; 203():108401. PubMed ID: 33326810
[TBL] [Abstract][Full Text] [Related]
7. Potential metabolomic biomarkers for reliable diagnosis of Behcet's disease using gas chromatography/ time-of-flight-mass spectrometry.
Ahn JK; Kim J; Hwang J; Song J; Kim KH; Cha HS
Joint Bone Spine; 2018 May; 85(3):337-343. PubMed ID: 28549946
[TBL] [Abstract][Full Text] [Related]
8. Discovery and Validation of Potential Serum Biomarkers for Pediatric Patients with Congenital Heart Diseases by Metabolomics.
Yu M; Sun S; Yu J; Du F; Zhang S; Yang W; Xiao J; Xie B
J Proteome Res; 2018 Oct; 17(10):3517-3525. PubMed ID: 30207476
[TBL] [Abstract][Full Text] [Related]
9. Analysis of metabolites and metabolic pathways in breast cancer in a Korean prospective cohort: the Korean Cancer Prevention Study-II.
Yoo HJ; Kim M; Kim M; Kang M; Jung KJ; Hwang SM; Jee SH; Lee JH
Metabolomics; 2018 Jun; 14(6):85. PubMed ID: 30830383
[TBL] [Abstract][Full Text] [Related]
10. Possibility of multivariate function composed of plasma amino acid profiles as a novel screening index for non-small cell lung cancer: a case control study.
Maeda J; Higashiyama M; Imaizumi A; Nakayama T; Yamamoto H; Daimon T; Yamakado M; Imamura F; Kodama K
BMC Cancer; 2010 Dec; 10():690. PubMed ID: 21176209
[TBL] [Abstract][Full Text] [Related]
11. Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics method.
Zhou Y; Song R; Ma C; Zhou L; Liu X; Yin P; Zhang Z; Sun Y; Xu C; Lu X; Xu G
Oncotarget; 2017 Mar; 8(13):20719-20728. PubMed ID: 28157703
[TBL] [Abstract][Full Text] [Related]
12. Identification of possible biomarkers for breast cancer from free fatty acid profiles determined by GC-MS and multivariate statistical analysis.
Lv W; Yang T
Clin Biochem; 2012 Jan; 45(1-2):127-33. PubMed ID: 22061338
[TBL] [Abstract][Full Text] [Related]
13. [Metabolomics for Biomarker Discovery in Systemic Lupus Erythematosus].
Saegusa J; Kawano S; Morinobu A
Rinsho Byori; 2015 Apr; 63(4):498-505. PubMed ID: 26536784
[TBL] [Abstract][Full Text] [Related]
14. Volatomic pattern of breast cancer and cancer-free tissues as a powerful strategy to identify potential biomarkers.
Silva C; Perestrelo R; Silva P; Capelinha F; Tomás H; Câmara JS
Analyst; 2019 Jul; 144(14):4153-4161. PubMed ID: 31144689
[TBL] [Abstract][Full Text] [Related]
15. UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer.
Wang X; Guan X; Tong Y; Liang Y; Huang Z; Wen M; Luo J; Chen H; Yang S; She Z; Wei Z; Zhou Y; Qi Y; Zhu P; Nong Y; Zhang Q
BMC Cancer; 2024 May; 24(1):644. PubMed ID: 38802800
[TBL] [Abstract][Full Text] [Related]
16. Exploration of candidate biomarkers for human psoriasis based on gas chromatography-mass spectrometry serum metabolomics.
Kang H; Li X; Zhou Q; Quan C; Xue F; Zheng J; Yu Y
Br J Dermatol; 2017 Mar; 176(3):713-722. PubMed ID: 27564527
[TBL] [Abstract][Full Text] [Related]
17. Liquid Chromatography-Mass Spectrometry-Based Metabolomics of Nonhuman Primates after 4 Gy Total Body Radiation Exposure: Global Effects and Targeted Panels.
Pannkuk EL; Laiakis EC; Gill K; Jain SK; Mehta KY; Nishita D; Bujold K; Bakke J; Gahagen J; Authier S; Chang P; Fornace AJ
J Proteome Res; 2019 May; 18(5):2260-2269. PubMed ID: 30843397
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of serum metabonome of patients with breast cancer by gas chromatography-mass spectrometry].
Wang J; Yu LF; Shen P; Wang SF
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 38(5):478-84. PubMed ID: 19830860
[TBL] [Abstract][Full Text] [Related]
19. LC-MS/MS platform-based serum untargeted screening reveals the diagnostic biomarker panel and molecular mechanism of breast cancer.
Gong S; Wang Q; Huang J; Huang R; Chen S; Cheng X; Liu L; Dai X; Zhong Y; Fan C; Liao Z
Methods; 2024 Feb; 222():100-111. PubMed ID: 38228196
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
